Home  >  Products  >  LYL1 (lymphoblastic leukemia derived sequence 1) Blocking Peptide (the N terminal of protein) (100ug)
LYL1 (lymphoblastic leukemia derived sequence 1) Blocking Peptide (the N terminal of protein) (100ug)

LYL1 (lymphoblastic leukemia derived sequence 1) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LYL1 antibody (Catalogue #: P100710_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP30931
Size: 100 ug
Weight: 30kDa
Gene: 4066
Format: Lyophilized powder
Target: LYL1 contains 1 basic helix-loop-helix (bHLH) domain. A chromosomal aberration, translocation t (7;19)(q35;p13) with TCRB, involving LYL1 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL).
See Full Product Listings >